A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial by Bell, KE et al.
RESEARCH ARTICLE
A whey protein-based multi-ingredient
nutritional supplement stimulates gains in
lean body mass and strength in healthy older
men: A randomized controlled trial
Kirsten E. Bell1, Tim Snijders1,2, Michael Zulyniak3, Dinesh Kumbhare3, Gianni Parise1,
Adrian Chabowski4, Stuart M. Phillips1*
1 Exercise Metabolism Research Group, Department of Kinesiology, McMaster University, Hamilton, ON,
Canada, 2 NUTRIM, Department of Human Biology and Movement Sciences, Maastricht University Medical
Center, Maastricht, The Netherlands, 3 Department of Medicine, McMaster University, Hamilton, ON,
Canada, 4 Department of Physiology, Medical University of Bialystok, Bialystok, Poland
* phillis@mcmaster.ca
Abstract
Protein and other compounds can exert anabolic effects on skeletal muscle, particularly in
conjunction with exercise. The objective of this study was to evaluate the efficacy of twice
daily consumption of a protein-based, multi-ingredient nutritional supplement to increase
strength and lean mass independent of, and in combination with, exercise in healthy older
men. Forty-nine healthy older men (age: 73 ± 1 years [mean ± SEM]; BMI: 28.5 ± 1.5 kg/m2)
were randomly allocated to 20 weeks of twice daily consumption of either a nutritional sup-
plement (SUPP; n = 25; 30 g whey protein, 2.5 g creatine, 500 IU vitamin D, 400 mg calcium,
and 1500 mg n-3 PUFA with 700 mg as eicosapentanoic acid and 445 mg as docosahexa-
noic acid); or a control (n = 24; CON; 22 g of maltodextrin). The study had two phases.
Phase 1 was 6 weeks of SUPP or CON alone. Phase 2 was a 12 week continuation of the
SUPP/CON but in combination with exercise: SUPP + EX or CON + EX. Isotonic strength
(one repetition maximum [1RM]) and lean body mass (LBM) were the primary outcomes. In
Phase 1 only the SUPP group gained strength (Σ1RM, SUPP: +14 ± 4 kg, CON: +3 ± 2 kg,
P < 0.001) and lean mass (LBM, +1.2 ± 0.3 kg, CON: -0.1 ± 0.2 kg, P < 0.001). Although
both groups gained strength during Phase 2, upon completion of the study upper body
strength was greater in the SUPP group compared to the CON group (Σ upper body 1RM:
119 ± 4 vs. 109 ± 5 kg, P = 0.039). We conclude that twice daily consumption of a multi-
ingredient nutritional supplement increased muscle strength and lean mass in older men.
Increases in strength were enhanced further with exercise training.
Trial Registration: ClinicalTrials.gov NCT02281331
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Introduction
Age-related declines in muscle mass and function, termed sarcopenia, contribute to various
negative health outcomes: metabolic disorders like type 2 diabetes mellitus and progression to
frailty [1]. Muscular strength is a strong and independent predictor of all-cause mortality in
older adults [2]; hence, solutions to attenuate sarcopenic declines are imperative [3]. Resis-
tance exercise training (RET), particularly when combined with nutritional supplements such
as protein [4] and creatine [5], is an effective strategy to counter muscle mass and strength
loss. In older adults, RET has also been shown to induce modest yet significant reductions in
cardiovascular disease risk [6], improvements in metabolic health [7] and aerobic capacity [8],
and reduce fall risk [9].
The combination of RET with protein and creatine supplementation is a potent stimulus
for increases in strength and lean mass. Recent studies also suggest that supplementation with
vitamin D [10] and omega-3 polyunsaturated fatty acids (n-3 PUFA) [11] may also be effective
in augmenting strength and hypertrophy. In addition to RET, evidence that high-intensity
interval training (HIIT) may stimulate muscle protein synthesis [12], improve glycemic regula-
tion [13], and increase aerobic capacity in older persons [14] is accumulating. Few studies
have employed a multicomponent supplement with a combination of exercise modalities in
older populations [15, 16]. However, such an approach may be prudent because individual
variability in response to nutritional supplementation, RET, and HIIT, is significant. There-
fore, a multicomponent nutritional strategy, especially when combined with multimodal exer-
cise training, would be more likely to yield a positive outcome in a greater proportion of older
persons compared to isolated supplements.
The primary objective of this trial was to determine whether twice daily consumption of
a supplement containing whey protein, creatine, calcium, vitamin D, and n-3 PUFA (rich
in eicosapentanoic acid [EPA] and docosahexanoic acid [DHA]) could stimulate gains in
strength, physical function, lean body mass, and metabolic health in a group of healthy
older men following 6 weeks of supplementation. We also determined if the addition of
exercise would potentiate supplement-mediated gains in strength, physical function, lean
body mass, and metabolic health following a 12 week combined RET + HIIT exercise pro-
gram. We hypothesized that our multi-ingredient supplement would induce improvements
in these outcomes independent of exercise and that we would observe an additive effect of
the supplement when combined with exercise training.
Methods
Screening and recruitment
Forty-nine health older men participated in this randomized, double-blind, placebo-con-
trolled parallel group trial which took place between December 2014 and September 2016
(see S1 File. Study Protocol). Potential participants were screened first by telephone to
ensure they were non-smokers  60 years old, had a body mass index (BMI) in the nor-
mal-overweight range (between 18.5 and 30.0 kg/m2), and had normal resting blood pres-
sure or stage I hypertension (systolic blood pressure [BP]  140–159 mmHg; diastolic
BP  90–99 mmHg). In the previous 6 months, potential participants had not partici-
pated in any structured resistance or aerobic exercise training program. Exclusion criteria
included: significant weight loss or gain in the past 6 months; regular use of: non-steroi-
dal anti-inflammatory drugs, simvastatin, atorvastatin, or anticoagulants; injuries pre-
venting safe participation in an exercise program; diabetes mellitus; cancer; infectious
disease; unstable cardiac; and/or gastrointestinal disease.
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To confirm eligibility, subjects were required to be non-diabetic, based on an oral glucose
tolerance test (OGTT; fasting blood glucose< 7.0 mM; 2 h blood glucose< 11.1 mM), com-
plete a physical activity readiness questionnaire (PAR-Q) [17], and demonstrate normal cardiac
function during a maximal exercise stress test on a cycle ergometer. This trial was approved
by the Hamilton Integrated Research Ethics Board and complied with the guidelines set out in
the Canadian Tri-Council policy statement on ethical conduct for research involving humans
(http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf). All participants were
informed of the nature and possible risks of the experimental procedures before their written
informed consent was obtained. This study ended in September 2016 upon completion of post
testing by the last group of participants to begin the protocol. Full details concerning the flow of
participants through this study can be found in Fig 1.
Sample sizes were calculated based on detection of increases in leg press isotonic strength
of 3.25 kg (standard deviation: 1.5 kg) observed during creatine supplementation combined
with RET in older persons compared to RET alone or with a placebo [5]. Assuming similar
response variance in our subjects during a 2-way repeated measures ANOVA and setting
power to 80% with alpha at 0.05 (2-tailed) yielded an estimate of 19 subjects per group. To be
conservative and allow for a potential 20% dropout rate we aimed for 25 subjects per group.
Experimental design
Eligible subjects were allocated to receive either a multi-ingredient nutritional supplement
(SUPP) or a control (CON) drink for 20 weeks (Fig 2). We employed a coded (group A versus
group B) block randomization scheme (block size: 10 participants) generated using http://www.
randomization.com/ to sequentially allocate subjects to groups in order of enrolment. A key to
the randomization code was held by an investigator who was not directly involved with subject
recruitment, training, or testing. Subjects, as well as investigators who were responsible for
recruiting, training, and/or testing subjects, were blind to the individual group assignments.
After 6 weeks of consuming their study beverages (Phase 1: SUPP or CON), subjects com-
pleted a 12 week supervised exercise training program while continuing to consume their
assigned beverages (Phase 2: SUPP + EX or CON + EX). Testing occurred at weeks -1 (pre-
intervention), 6, and 19. The following assessments were conducted over the course of each
testing week: isotonic strength (one repetition maximum [1RM]), aerobic fitness (peak oxygen
uptake [VO2peak]), physical function, body composition by dual-energy x-ray absorptiometry
(DXA), OGTT, dietary intake (3-day food records), and habitual physical activity
(accelerometer).
Nutritional supplements
The experimental supplement was composed of whey protein, creatine, calcium, vitamin D,
and n-3 PUFA. All ingredients except for the n-3 PUFA (and control oil) were packaged in
powder form in individual sachets (Infinit Nutrition, Windsor, ON). Subjects prepared the
beverages at home by mixing the contents of 1 sachet with 425 mL water and consumed two
drinks daily: 1 h after breakfast, and again 1h prior to retiring to bed. Subjects measured out
and consumed 10 mL of oil once per day (the SUPP oil contained 3000 mg n-3 PUFA with
1400 mg eicosapentanoic acid [EPA] and 890 mg docosahexaenoic acid [DHA]; CON was
safflower oil) with their morning study beverage. The powder and oil provided to the CON
group were matched in flavor and odour to the active forms. The exact composition of and
nutrition information for the supplement and control drinks and oils can be found in
Table 1. All study beverages and oils were labelled in a blinded manner (Infinit Nutrition,
Multi-ingredient protein-based supplement in aging
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Windsor, ON). Participants were instructed not to alter their habitual dietary or physical
activity habits for the duration of the study.
Exercise training
The 12 week progressive exercise training program took place at McMaster University. Sub-
jects completed twice weekly RET (Mon and Fri) and once weekly HIIT (Wed).
The RET sessions began with a 5 min warm-up on a cycle ergometer, and thereafter sub-
jects performed 3 sets of 4 separate exercises in the following order: leg press, chest press or lat-
eral pull-down, horizontal row or shoulder press, and leg extension. Chest press and
Fig 1. CONSORT flow diagram illustrating the movement of participants through the study, which was conducted
between December 2014 and September 2016 (see S2 File. CONSORT Checklist).
https://doi.org/10.1371/journal.pone.0181387.g001
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horizontal row were only performed on Monday, and lateral pull-down and shoulder press
were only performed on Friday (leg press and leg extension were performed at every RET ses-
sion). The RET sessions were concluded with a 5 min cool-down on a cycle ergometer. During
the first 3 weeks of exercise training, workload was gradually increased from 65% 1RM (10–12
repetitions) to 80% 1RM (6–8 repetitions). The third set of each exercise was always completed
until volitional fatigue, which we defined as the inability to complete an addition repetition
with proper form. Loads were adjusted based on 1RM strength tests or when subjects could
complete 12 repetitions during the third set of each exercise.
Participants performed HIIT on a cycle ergometer (ISO1000 Upright Bike; SCIFIT, Tulsa,
OK) while wearing a heart rate (HR) monitor (H7 Heart Rate Sensor; Polar Electro Canada,
Lachine, QC). Following a 3 min warm-up at 25 W, subjects completed 10 x 60 s intervals at a
workload which elicited ~90% maximal HR (HRmax), while maintaining a cadence of 90
Fig 2. Schematic of study design. Participants consumed either a multi-ingredient protein-based nutritional supplement (SUPP) or control (CON) drink for
20 weeks total (from weeks 0–19, inclusive), and completed a 12 week exercise training program (RET twice per week and HIIT once per week) between
weeks 7–18. Testing occurred at weeks -1 (baseline), 6, and 19, and included the following assessments: isotonic strength (1RM), aerobic fitness (VO2peak),
physical function, body composition (DXA), and a 75g OGTT. Phase 1: SUPP/CON took place between weeks 0–6, and Phase 2: SUPP/CON + EX took
place between weeks 7–19. 1RM, one repetition maximum; DXA, dual-energy x-ray absorptiometry; HIIT, high-intensity interval training; OGTT, oral glucose
tolerance test; RET, resistance exercise training; VO2peak, peak oxygen uptake.
https://doi.org/10.1371/journal.pone.0181387.g002
Table 1. Nutritional composition of the study drinks and oils.
SUPP CON
Whey protein (g) 30 0
Creatine (g) 2.5 0
Calcium (mg) 400 0
Vitamin D (IU) 500 0
Carbohydrate (g) 1 22
Energy (kcal) 116 56
Oil
EPA (mg) 1400 0
DHA (mg) 890 0
The quantities listed below represent a single drink and a single serving of oil. Participants consumed two
drinks per day and one serving of oil per day.
SUPP, supplement; CON, control; EPA, eicosapentanoic acid; and DHA, docosahexaenoic acid.
https://doi.org/10.1371/journal.pone.0181387.t001
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rpm. Workload was adjusted as needed to maintain an average HR of ~90% HRmax over the
10 intervals. Intervals were interspersed with 60 s of rest where subjects cycled at a self-selected
pace against 25 W. HIIT sessions were concluded with a 5 min cool-down at 25 W.
Strength assessments
At baseline, proper lifting technique was demonstrated and practiced by participants during a
familiarization session. Muscle strength was assessed using 1RM strength tests for the follow-
ing exercises: leg press, chest press, lateral pull-down, horizontal row, shoulder press, and leg
extension (HUR; Northbrook, IL). The 1RM load was reassessed four days after the initial
assessment as previously described [18]. Strength is reported as individual 1RMs for each of
the six exercises, as well as the sum of upper body 1RMs (horizontal row, chest press, lateral
pull-down, and shoulder press), the sum of lower body 1RMs (leg extension and leg press),
and the sum of all 1RMs.
Aerobic fitness testing
Subjects performed a VO2peak test on an electronically braked cycle ergometer (Lode Excali-
bur Sport V 2.0; Groningen, The Netherlands) while wearing a chest-strap HR monitor. A
metabolic cart and online gas collection system (MOXUS Modular Oxygen Uptake System;
AEI Technologies, Pittsburgh, PA) were used to quantify respiratory gases. Following a 1 min
warm-up at 30 W, the load was increased by 1 W every 4 s. Participants were instructed to
maintain a cadence of 60–90 rpm, and tests were terminated if the cadence dropped below 55
rpm for> 10 s, or if volitional fatigue was attained.
Physical function
Subjects completed 3 assessments to measure physical function. The 30 s chair stand required
subjects to rise from a chair without the use of their arms as many times as possible in 30 s
[19]. For the timed up-and-go (TUG), subjects were instructed to rise from the same chair,
walk to and from a clearly marked point a distance of 3 m away, and sit back down in the
shortest amount of time possible. Subjects were given a practice trial before both the 30 s chair
stand and the TUG, and the average of 3 trials (with 3 min rest allowed between trials) was
recorded for each outcome. Lastly, the 6 min walk test was performed on a 200 m indoor
track. Subjects were instructed to attempt to cover as much distance as possible within 6 min
while walking in a safe manner at their usual walking speed.
Body composition
Whole body and regional lean soft tissue mass (i.e. fat-free and bone-free mass), fat mass, and
bone mineral content were measured using DXA (GE-LUNAR iDXA; GE, Mississauga, ON)
following a 10–12 h overnight fast. Regional body compartment analysis was performed in
batches by a single investigator who was blinded to group assignment. Waist and hip circum-
ferences were measured at the top of the iliac crests and at the widest portion of the hips,
respectively, using a tape measure while participants stood with their arms relaxed and feet
together.
Oral glucose tolerance test
After a 10h overnight fast, a 20 G catheter was inserted into an antecubital vein and a fasting
blood sample (0 min) was obtained. Subjects then consumed a 75 g dextrose solution (Trutol™;
NERL Diagnostics LLC, East Providence, RI) within 5 min. Serial blood samples were obtained
Multi-ingredient protein-based supplement in aging
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at 30, 60, 90 and 120 min post-ingestion of the dextrose beverage for the measurement of
plasma glucose and insulin concentrations. We calculated total (i,e. baseline values not sub-
tracted) incremental area under the curve (AUC) for glucose and insulin using GraphPad
Prism 7.0 (La Jolla, CA), according to previously described methods [20]. The Matsuda Index
of insulin sensitivity was calculated using the equation formulated by Matsuda and Defronzo
[21].
Dietary intake
Three-day food records (2 weekdays and 1 weekend day) were analyzed using ESHA (Food
Processor Nutrition Analysis Software; Salem, OR). Subjects were instructed by research staff
on how to record the types and quantities of food, beverages, study drinks/oil, and other nutri-
tion supplements or vitamins that they consumed during this period. Baseline 3-day food rec-
ords were completed prior to commencing the study protocol.
Biochemical analysis
Plasma glucose concentrations were measured using the glucose oxidase method (YSI 2300;
Yellow Springs, OH). Plasma insulin concentrations were measured using the dual-site chemi-
luminescent method (Siemens Immulite 2000; Malvern, PA). Cholesterol (total, high-density
lipoprotein [HDL], and low-density lipoprotein [LDL]) and triglycerides (TG) were analyzed
using the Architect Clinical Chemistry Analyzer (Abbott Diagnostics; Lake Forest, IL). Plasma
25 hydroxyvitamin D (25[OH]D) concentrations were measured by radioimmunoassay using
a commercially available kit (DiaSorin Canada; Mississauga, ON), and plasma cystatin C con-
centrations were measured with a BN100 Nephelometer (Dade Behring; Deerfield IL) using a
particle-enhanced immunonephelometric assay.
Erythrocyte membrane phospholipid composition was measured as described previously
[22]. Briefly, total lipids from the samples were extracted [23], and thin layer chromatography
was used to separate individual classes of phospholipids (phosphatidylcholine, PC; phosphati-
dylethanolamine, PE; phosphatidylinositol, PI; phosphatidylserine, PS; and sphingomyelin,
SM). Once isolated, phospholipids were methylated with 1 M methanolic sodium methoxide
at room temperature for 10 min [24], and the fatty acid composition of each class of phospho-
lipids was analyzed by gas chromatography (Hewlett-Packard 5890 Series II System, equipped
with a double flame ionization detector, and Agilent CP-Sil 88 capillary column, 100 m, inter-
nal diameter of 0.25 mm) [25, 26]. Fatty acids were identified by comparing retention times to
those of a known standard, and absolute amounts of individual fatty acids were calculated with
the aid of an internal standard (pentadecanoic acid), which was added to samples before the
methylation process. Total amounts of each phospholipid were determined from the sum of
fatty acids in each fraction.
Statistical analysis
Statistical analysis was completed using IBM SPSS software (IBM SPSS Statistics for Windows,
version 23.0; IBM Corp., Armonk, NY). We conducted an intention-to-treat analysis using a
linear mixed model with an unstructured covariance matrix including group (SUPP or CON),
time (prior to study entry, and weeks 6 and 19), and the group-by-time interaction as fixed fac-
tors; subject as a random factor; and respective baseline values as covariates. Following signifi-
cant group-by-time interactions, significant between (SUPP or CON) and within (weeks -1, 6,
or 19) group differences were identified using post hoc tests with a Bonferroni correction for
multiple comparisons. Based on recommendations for human clinical trials with missing data
Multi-ingredient protein-based supplement in aging
PLOS ONE | https://doi.org/10.1371/journal.pone.0181387 July 18, 2017 7 / 18
[27], all participants (completers as well as participants who withdrew prior to week 6 or week
19 testing) were included in the final analysis, and missing values were not replaced.
We also conducted an exploratory sub-analysis to examine whether baseline vitamin D sta-
tus affected the amount of strength gained by participants in the SUPP group. For this sub-
analysis we used a linear mixed model with an unstructured covariance matrix including sub-
group (inadequate [< 50 nM] or adequate [ 50 nM] baseline plasma 25[OH]D, time (Phase
1 or 2), and the subgroup-by-time interaction as fixed factors; and subject as a random factor.
Following significant subgroup-by-time interactions, significant between (inadequate or ade-
quate baseline vitamin D status) and within (Phase 1 or 2) subgroup differences were identified
using post hoc tests with a Bonferroni correction for multiple comparisons.
For all statistical analyses significance was accepted as P< 0.05. Data are presented as
means ± standard error of the mean (SEM).
Results
Participants
Forty-nine older men were randomized: 38 completed the study and 11 dropped out (n = 7 and
n = 4 dropouts in the SUPP and CON groups, respectively). Of the participants who dropped out,
4 withdrew prior to week 6 testing (during Phase 1), and 7 withdrew partway through the exercise
training program and prior to week 19 testing (during Phase 2). Reasons for withdrawal from the
study are provided in Fig 1. Participants’ baseline characteristics are presented in Table 2.
Compliance
Compliance (based on self-report as well as returned sachets) with beverage consumption was:
SUPP = 87 ± 2%; CON = 92 ± 2%. A similar degree of compliance was observed with oil con-
sumption: SUPP = 92 ± 2%; CON = 95 ± 2%. Subjects in the SUPP and CON groups attended
95 ± 1% and 94 ± 1% of their prescribed training sessions, respectively. All subjects attended at
least 80% of all RET and HIIT sessions.
Blood
We assessed plasma 25(OH)D concentrations at weeks -1, 6, and 19. Concentrations of 25
(OH)D were 44.3 ± 2.6 nM (SUPP) and 37.6 ± 2.8 nM (CON) at baseline (range: 21.0–64.2
nM; Table 2), and increased significantly in the SUPP group (to 50.5 ± 3.1 nM at week 6 and
57.1 ± 3.9 nM at week 19; P< 0.001). No change was observed in the CON group over the
course of study (37.3 ± 2.6 nM at week 6 and 35.6 ± 2.5 nM at week 19; P> 0.05).
Erythrocyte membrane phospholipids were measured as described in detail previously [22],
and the content of EPA plus DHA increased 90% (phosphatidylcholine), 22% (phosphatidyl-
serine), 65% (phosphatidylinositol), and 43% (phosphatidylethanolamine) between baseline
and week 6 in the SUPP group, and each increased an additional ~30% by week 19. The EPA
plus DHA content of erythrocyte membranes did not change significantly over the course of
the study in the CON group.
Cystatin C concentrations were 0.85 ± 0.03 mg/L (SUPP) and 0.83 ± 0.05 mg/L (CON) at
baseline (range: 0.60–1.08 mg/L; see Table 2), and did not change significantly over the course
of the study in either group.
Isotonic muscle strength
Significant group-by-time interactions were observed for the sum of all 1RMs (P = 0.039) and
upper body 1RMs (P = 0.015), as shown in Fig 3. In the SUPP group, the sum of all 1RMs
Multi-ingredient protein-based supplement in aging
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increased by 3% during Phase 1 from 206 ± 7 kg at baseline to 212 ± 8 kg at week 6 (P< 0.001;
Fig 3A) and a further 20% during Phase 2 (P< 0.001). In the CON group, there was no change
in total (Fig 3A) or upper body (Fig 3B) strength during Phase 1. However, following Phase 2
the sum of all 1RMs increased by 21% (P< 0.001; Fig 3A) and the sum of upper body 1RMs
increased by 11% (P< 0.001; Fig 3B) in the CON group.
Body composition
We observed significant group-by-time interactions for whole body lean mass (P< 0.01),
appendicular lean mass (P = 0.021), leg lean mass (P = 0.015), and trunk lean mass (P< 0.01).
In the SUPP group, whole body lean mass increased by 0.7 kg in Phase 1 (P< 0.001; Fig 4A);
however, no further increase was observed during Phase 2. Likewise, in the SUPP group at
week 6 we observed increases in appendicular lean mass of 0.4 kg (P< 0.01; Fig 4B), leg lean
mass of 0.3 kg (P< 0.01; Fig 4C), and trunk lean mass of 0.4 kg (P = 0.002; Table 3) compared
to baseline. However, no further changes in appendicular, leg, or trunk lean mass were
observed during Phase 2. In the CON group, conversely, we did not observe any significant
change in whole body lean mass (Fig 4A) or regional measurements of lean mass over the
course of the study.
Table 2. Baseline characteristics of participants.
SUPP (n = 25) CON (n = 24)
Age (years) 71 ± 1 74 ± 1
Systolic BP (mm Hg) 138 ± 4 138 ± 3
Diastolic BP (mm Hg) 78 ± 2 78 ± 2
Body mass (kg) 85.3 ± 2.4 84.5 ± 2.5
Height (m) 1.72 ± 0.01 1.73 ± 0.01
BMI (kg/m2) 28.9 ± 0.8 28.1 ± 0.7
Whole body lean mass (kg) 54.0 ± 1.1 54.5 ± 1.4
Whole body fat mass (kg) 28.2 ± 1.7 26.8 ± 1.4
% body fat 33.6 ± 1.3 32.6 ± 1.0
Waist:hip ratio 0.99 ± 0.01 0.99 ± 0.01
Leg extension 1RM (kg) 27 ± 1 27 ± 2
Leg press 1RM (kg) 77 ± 3 69 ± 4
VO2peak (mL/kg/min) 23.8 ± 0.8 24.4 ± 0.9
Peak power (W) 154 ± 5 158 ± 7
Fasting glucose (mM) 5.6 ± 0.1 5.8 ± 0.1
2h glucose (mM) 6.8 ± 0.4 7.2 ± 0.4
HOMA-IR 2.1 ± 0.1 2.2 ± 0.1
Total-c (mM) 4.69 ± 0.22 4.83 ± 0.19
LDL-c (mM) 2.74 ± 0.21 2.87 ± 0.18
HDL-c (mM) 1.27 ± 0.06 1.29 ± 0.06
TG (mM) 1.49 ± 0.19 1.50 ± 0.21
25(OH)D (nM) 44.3 ± 2.6 37.6 ± 2.8
Cystatin C (mg/L) 0.85 ± 0.03 0.83 ± 0.05
Data are means ± SEM. 25(OH)D, 25 hydroxyvitamin D; SUPP, supplement; CON, control; BP, blood
pressure; BMI, body mass index; 1RM, one repetition maximum; HOMA-IR, homeostatic model assessment
of insulin resistance; VO2peak, peak oxygen uptake; Total-c, total cholesterol; LDL, low-density lipoprotein;
HDL, high-density lipoprotein; TG, triglycerides.
https://doi.org/10.1371/journal.pone.0181387.t002
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Whole body fat mass increased significantly (P = 0.032) by ~0.2 kg during Phase 1 (SUPP:
-1% and CON: +3%; Table 3) and subsequently decreased by 0.9 kg (P = 0.020) during Phase 2
(SUPP: -8% and CON: 0%).
Vitamin D status sub-analysis
At baseline, 9/25 participants in the SUPP group had adequate vitamin D status. We observed
a significant subgroup-by-time interaction for chest press and the sum of upper body 1RM
strength (both P< 0.001). During Phase 1 participants in the SUPP group with inadequate
and adequate baseline plasma 25(OH)D gained similar amounts of muscular strength. How-
ever during Phase 2, participants with inadequate baseline vitamin D status increased chest
press (+4 ± 3 vs. +1 ± 4 kg, P = 0.041) and sum of upper body (+15 ± 7 vs. +7 ± 6 kg, P = 0.034)
1RM strength to greater extent compared to participants in the adequate subgroup.
Fig 3. Isotonic strength expressed as the sum of all (A), upper body (B), and lower body (C) 1RMs. Boxes (SUPP: grey; CON: white) represent
interquartile (25th to 75th percentile) ranges, with the horizontal lines indicating the median. Whiskers represent the maximal and minimal values, and the
cross indicates the mean. Data were analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and 19),
and the group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. We observed significant group-by-
time interactions for the sum of all 1RMs (P = 0.039) and for the sum of upper body 1RMs (P = 0.015), and a main effect of time for the sum of lower
body 1RMs (P < 0.001). Dissimilar letters denote changes over time within a given treatment group (SUPP or CON). * Indicates a significant (P < 0.05)
difference from the CON group at that time. 1RM, one repetition maximum; SUPP, supplement group (n = 25); CON, control group (n = 24).
https://doi.org/10.1371/journal.pone.0181387.g003
Fig 4. Whole body (A), appendicular (B), and leg (C) lean mass over the course of the study. Boxes (SUPP: grey; CON: white) represent
interquartile (25th to 75th percentile) ranges, with the horizontal lines indicating the medians. Whiskers represent the maximal and minimal values, and
the crosses indicate the means. Data was analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and
19), and the group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. We observed significant group-
by-time interactions for whole body (P < 0.01), appendicular (P = 0.021), and leg lean mass (P = 0.015). Dissimilar letters denote changes over time
within a given treatment group (SUPP or CON). SUPP, supplement group (n = 25); CON, control group (n = 24).
https://doi.org/10.1371/journal.pone.0181387.g004
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Physical function and aerobic fitness
We observed time-dependent increases in TUG, the 6 min walk test, VO2peak, and peak
power (all P< 0.001; Table 4). There were no significant changes during Phase 1; however, sig-
nificant improvements were made following Phase 2. Between weeks 6 and 19, the time taken
to complete the TUG decreased by ~0.3 s (SUPP: -7% and CON: -3%; P = 0.004), and the dis-
tance covered in the 6 min walk test increased by ~25 m (P< 0.001). In addition, relative
VO2peak increased overall by 1.8 mL/kg/min, and peak power increased by 13 W (P< 0.001).
We did not observe any significant changes in the 30 s chair stand test over the course of
study.
Glucose tolerance
Glucose area under the curve (AUC, P = 0.002), insulin AUC (P< 0.001), the homeostatic
model assessment of insulin resistance (HOMA-IR, P< 0.001), and the Matsuda index of
Table 3. Anthropometric and DXA-derived body composition.
SUPP CON
Baseline 6wk 19wk Baseline 6wk 19wk
Body mass (kg)2 85.3 ± 2.4a 85.9 ± 2.6b 83.1 ± 2.6a,b 84.5 ± 2.5a 85.3 ± 2.7b 85.9 ± 2.8a,b
BMI (kg/m2)2 28.9 ± 0.8a 29.2 ± 0.8b 28.9 ± 0.9a,b 28.1 ± 0.7a 28.4 ± 0.8b 28.5 ± 0.8a,b
Fat mass (kg)2 28.2 ± 1.7a 28.0 ± 1.9b 25.9 ± 2.0b 26.8 ± 1.4a 27.5 ± 1.5b 27.5 ± 1.6a,b
% body fat2 33.6 ± 1.3a,b 33.2 ± 1.4a 31.7 ± 1.6b 32.6 ± 1.0a,b 33.0 ± 1.1a 32.9 ± 1.1b
Arm lean mass (kg)2 6.3 ± 0.2a 6.4 ± 0.2b 6.4 ± 0.2b 6.3 ± 0.2a 6.4 ± 0.2b 6.5 ± 0.2b
Trunk lean mass (kg)1 25.1 ± 0.5a 25.5 ± 0.6b 25.2 ± 0.6b 25.5 ± 0.6a 25.4 ± 0.6a 25.5 ± 0.7a
Waist circumference (cm) 105 ± 2 105 ± 2 104 ± 2 104 ± 2 105 ± 2 104 ± 2
Hip circumference (cm) 106 ± 1 107 ± 1 107 ± 1 106 ± 1 106 ± 2 107 ± 2
Waist:hip ratio2 0.99 ± 0.01a,c 0.99 ± 0.01b,c 0.97 ± 0.01a 0.99 ± 0.01a,c 0.99 ± 0.01b,c 0.97 ± 0.01a
Values are means±SEM and were analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and 19), and the
group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. For each outcome, different superscript letters
represent significant differences over time within each group. Significance accepted as P < 0.05. DXA, dual-energy x-ray absorptiometry; BMI, body mass
index; SUPP, supplement group (n = 25); CON, control group (n = 24).
1Group-by-time interaction (P < 0.05).
2Main effect for time (P < 0.05).
https://doi.org/10.1371/journal.pone.0181387.t003
Table 4. Physical function and aerobic fitness assessments.
SUPP CON
Baseline 6wk 19wk Baseline 6wk 19wk
30s chair stand (stands)1 12 ± 1a 13 ± 1a,b 13 ± 1b 13 ± 1a 13 ± 1a,b 13 ± 1b
Timed up-and-go (s)1 7.1 ± 0.2a 6.9 ± 0.3a 6.4 ± 0.2b 7.6 ± 0.3a 7.0 ± 0.3a 6.8 ± 0.3b
6 min walk (m)1 576 ± 14a 585 ± 15a 616 ± 19b 593 ± 17a 621 ± 16a 639 ± 23b
VO2peak (mL/kg/min)1 23.8 ± 0.8a 24.6 ± 0.9a 26.2 ± 1.2b 24.4 ± 0.9a 24.4 ± 1.1a 26.4 ± 1.4b
Peak power (W)1 154 ± 5a 157 ± 5a 164 ± 7b 158 ± 7a 158 ± 7a 178 ± 10b
Values are mean ± SEM and were analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and 19), and the
group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. For each outcome, different superscript letters
represent significant differences over time within each group. Significance accepted as P < 0.05. SUPP, supplement group (n = 25); CON, control group
(n = 24); TUG, timed up-and-go; VO2peak, peak oxygen uptake.
1Main effect for time (P < 0.05).
https://doi.org/10.1371/journal.pone.0181387.t004
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insulin sensitivity (P< 0.001) all improved in a time-dependent manner following Phase 2
(Table 5). Interestingly, we noted a reduction in maximal glucose concentrations (Cmax) and
mean glucose in the SUPP group that was progressive across the study, with no change in
CON group.
Fasting lipids
We observed significant time-by-group interactions for TG (P = 0.023) and total cholesterol
(P = 0.014), shown in Table 5. In the SUPP group, TG (-35%; P< 0.01) and total cholesterol
(-7%; P = 0.003) were reduced following Phase 1 with no further reduction during Phase 2. In
the CON group no change in TG was observed over the course of the study, however, total
cholesterol decreased significantly (-3%; P = 0.026) following Phase 2.
Dietary intake
We observed, as expected, significant group-by-time interactions for protein intake (expressed
as g, g/kg body mass, and % energy; P< 0.001; Table 6), vitamin D (P< 0.001), calcium
(P< 0.001), and n-3 PUFA (P = 0.003). In the CON group, we did not observe any significant
change in macro- or micronutrient intake over the course of the intervention. A significant
main effect of time was observed for daily energy intake (P = 0.004). Total energy intake was
significantly higher at week 6 compared to baseline (SUPP: +12%; CON: +9%, P = 0.005), with
no further change following Phase 2.
Discussion
We report that twice daily consumption of a whey protein-based, multi-ingredient supplement
resulted in significant gains in muscle strength and lean mass. In addition, muscle strength,
physical function, aerobic capacity and metabolic health were further improved in response to
Table 5. Fasting blood lipids and insulin sensitivity indices.
SUPP CON
Baseline 6wk 19wk Baseline 6wk 19wk
Total-c (mM)1 4.69 ± 0.22a 4.34 ± 0.23b 4.56 ± 0.30a,b 4.83 ± 0.19a,b 4.86 ± 0.19a 4.73 ± 0.19b
LDL-c (mM) 2.74 ± 0.21 2.63 ± 0.19 2.77 ± 0.25 2.87 ± 0.18 2.87 ± 0.20 2.85 ± 0.19
HDL-c (mM) 1.27 ± 0.06 1.27 ± 0.08 1.28 ± 0.09 1.29 ± 0.06 1.29 ± 0.06 1.26 ± 0.07
TG (mM)1 1.49 ± 0.19a 0.97 ± 0.09b* 1.10 ± 0.14b 1.50 ± 0.21a 1.52 ± 0.18a 1.35 ± 0.16a
Glucose AUC (mM•120min)2 915 ± 16a 890 ± 10a 842 ± 14b 886 ± 11a 899 ± 12a 869 ± 13b
Mean plasma glucose (mM)1 7.2 ± 0.1a 7.0 ± 0.1a,b 6.7 ± 0.1b 7.0 ± 0.1a 7.1 ± 0.1a 6.9 ± 0.1a
Plasma glucose Cmax (mM)1 9.6 ± 0.3a 9.1 ± 0.2a,b 8.5 ± 0.2b 8.9 ± 0.2a 9.1 ± 0.2a 9.1 ± 0.2a
Insulin AUC (μIU/mL•120min)2 4080 ± 65a 3950 ± 77a 3533 ± 62b 4060 ± 69a 3951 ± 92a 3397 ± 68b
HOMA-IR2 2.1 ± 0.1a 2.1 ± 0.1a 1.7 ± 0.1b 2.2 ± 0.1a 2.0 ± 0.1a 1.7 ± 0.1b
Matsuda Index2 5.1 ± 0.7a 5.3 ± 0.6a 6.4 ± 0.8b 5.1 ± 0.6a 5.4 ± 0.8a 6.4 ± 0.8b
Values are mean ± SEM and were analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and 19), and the
group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. For each outcome, different superscript letters
represent significant differences over time within each group. Significance accepted as P < 0.05. SUPP, supplement group (n = 25); CON, control group
(n = 24); Total-c, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglyceride; Cmax, maximum concentration; AUC, area
under the curve; HOMA-IR, homeostatic model assessment of insulin resistance.
1Group-by-time interaction (P < 0.05).
2Main effect for time (P < 0.01).
*Represents a significant difference from CON at that time point.
https://doi.org/10.1371/journal.pone.0181387.t005
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a 12 week combined exercise training program. Some, but not all, outcomes were improved to a
greater extent with supplementation. While it is not possible to isolate which compounds in the
supplement were responsible for the outcomes observed, each ingredient has been shown to
independently affect aspects of sarcopenia and thus has a rational basis for inclusion. Notably,
whey protein supplementation can variably enhance lean mass and strength [4, 28–31], creatine
can improve strength [5, 32] vitamin D supplementation can reduce the risk of falls [33] and
fractures [34], and n-3 PUFA has been shown it to improve muscle quality [35], mass [11], and
function [11, 35] in older adults. However, the response heterogeneity for all relevant variables
to the individual compounds provides a rationale for why a combination of ingredients could
be more efficacious than any of the compounds alone. We excluded women from this relatively
small trial in an attempt to reduce the variability in strength and lean body mass measurements.
Given that women make up a large proportion of older adults and may be more vulnerable than
men to anabolic resistance [36], we acknowledge this as a major limitation.
Some studies [11, 37, 38] have demonstrated a beneficial effect of nutritional supplementa-
tion independent of exercise on muscle strength, physical function, and lean mass in older
adults, but others have not [39, 40]. This discrepancy may, in part, be explained by a heterogene-
ity of response to supplementation in older adults. By employing a multi-ingredient approach
to dietary supplementation we hypothesized that we would be more likely to influence more
than one potentially important pathway/mechanism through which older persons would derive
an anti-sarcopenic effect. The present study clearly showed increases in total muscle strength
and lean mass in response to a multi-ingredient nutritional supplement in the absence of exer-
cise training. Other trials using a combination of ingredients (whey protein [leucine] and vita-
min D) similar in dose to those we employed in our supplement have shown preservation of
Table 6. Daily dietary intakes via self-report from 3-day food records.
SUPP CON
Baseline 6 wk 19 wk Baseline 6 wk 19 wk
Energy (kcal)2 2146 ± 488a 2405 ± 701b 2375 ± 153a,b 2336 ± 553a 2541 ± 590b 2417 ± 757a,b
Protein
g1 89 ± 24a 142 ± 34b* 130 ± 25b* 97 ± 27a 100 ± 35a 99 ± 41a
g/kg body mass1 1.1 ± 0.3a 1.7 ± 0.5b* 1.6 ± 0.4b* 1.2 ± 0.3a 1.2 ± 0.4a 1.2 ± 0.5a
%1 17 ± 3a 24 ± 5b* 26 ± 5b* 17 ± 4a 16 ± 4a 17 ± 5a
Carbohydrate
G 265 ± 65 257 ± 87 223 ± 63 272 ± 102 309 ± 96 304 ± 121
%1 50 ± 6a 43 ± 6b* 43 ± 6b* 46 ±12a 49 ± 10a 51 ± 13a
Fat
G 71 ± 22 82 ± 34 68 ± 32 86 ± 30 89 ± 35 80 ± 34
% 30 ± 6 30 ± 6 28 ± 6 33 ± 8 31 ± 8 29 ± 8
Vitamin D (IU)1 161 ± 128a 1061 ± 220b* 1086 ± 168b* 175 ± 140a 193 ± 205a 148 ± 169a
Calcium (mg)1 775 ± 354a 1491 ± 617b* 1423 ± 305b* 944 ± 553a 919 ± 517a 856 ± 499a
n-3 PUFA (g)1 1.2 ± 1.4a 2.5 ± 1.4b* 2.3 ± 0.8b* 0.9 ± 0.7a 1.2 ± 1.0a 1.1 ± 1.3a
Values are mean ± SEM and were analyzed using a linear mixed model with group (SUPP or CON), time (prior to study entry, and weeks 6 and 19), and the
group-by-time interaction as fixed factors; subject as a random factor; and baseline values as covariates. For each outcome, different superscript letters
represent significant differences over time within each group. Significance accepted as P < 0.05. SUPP, supplement group (n = 25); CON, control group
(n = 24); n-3 PUFA, omega-3 polyunsaturated fatty acids.
1Group-by-time interaction (P < 0.05).
2Main effect for time (P < 0.01).
*Represents a significant difference from CON at that time point.
https://doi.org/10.1371/journal.pone.0181387.t006
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lean mass during weight loss [15], enhanced strength [16], increased lean body mass [16], and
enhanced physical function (in sarcopenic older persons) [16]. Such changes in lean body mass
and strength are clinically relevant given that strength and muscle mass decrease at the respec-
tive rates of ~1–3% and ~0.5–1% annually, likely commencing in or around the fifth decade of
life [41]. Notably, the gains in strength and lean body mass we observed would be the equivalent
of offsetting about one year of age-related decline in these variables, suggesting that this formu-
lation, especially when combined with exercise, could mitigate the progression of sarcopenia.
Exercise training is another highly effective intervention to counter sarcopenia. Resistance
exercise, in particular, acutely elevates myofibrillar protein synthesis for several days [12],
resulting in long-term gains in muscle mass and strength in older adults when practiced regu-
larly [42, 43]. Previously, we have shown that a single bout of high intensity interval exercise
stimulates myofibrillar protein synthesis in older adults [12]. High intensity interval exercise
offers numerous other health benefits in both younger and older populations, such as improve-
ments in glycemic regulation [13] and aerobic capacity [14]. Knowing that aging is associated
with reduced cardiometabolic health, as well as low muscularity and strength, we designed an
exercise training program that combined exercise modalities for optimal benefit in older
adults. Our data show that RET and HIIT can be safely used in combination to elicit significant
gains in lean mass, strength, and physical function. Additionally, markers of cardiometabolic
health, such as aerobic capacity and glucose tolerance, also improved in this sample of older
men (Table 5). The lack of a significant increase in lean mass during Phase 2 is likely due to
the relatively low volume of resistance exercise performed by participants in the current study
compared to previous studies [44]. It is also possible that there was a potential antagonizing
effect of concurrent exercise (i.e., HIIT) on RET-induced adaptations [45]. Nonetheless, the
significant gains in muscle strength and function that we observed following exercise training
may be important for physical function, mobility, and a higher quality of life [46].
We show that consumption of the multi-ingredient supplement during the exercise training
program (Phase 2) resulted in superior gains in upper body strength compared to CON; how-
ever, we did not observe the same findings in lower body or overall muscle strength (Fig 3),
lean mass (Fig 4), or physical function (Table 4). Several previous studies have failed to identify
an additional beneficial effect of nutritional supplementation on exercise-mediated gains in
lean mass and strength [35, 47–49]. Conversely, other studies have reported a positive effect
[50–52]. Sample size may have limited our ability to detect a difference between the supple-
ment and control group over the course of exercise training. A post hoc calculation revealed
that we would have required 80 participants per group to detect a difference in the magnitude
of overall strength. The relative good health of the participants included in the present study
also may have prevented us from observing such an effect. We postulate that if the same exer-
cise and nutrition intervention were applied to a more frail/functionally impaired group of
older adults [16], it is possible that the same multi-ingredient supplement would be even more
efficacious.
The current results demonstrate that this multi-ingredient supplement may be beneficial in
patients for whom structured exercise is not possible or who are undergoing periods of muscle
disuse. This is of particular importance since the relatively slow and steady decline in strength
and muscle mass with age is often punctuated by brief periods of muscle disuse (i.e., during
hospitalization) where losses are accelerated [53, 54]. While we cannot isolate the effects of spe-
cific nutrients some associations we observed are, we propose, noteworthy. In an exploratory
subgroup analysis, we observed that a transition from insufficient vitamin D status (serum 25
[OH]D < 50 nM) at baseline to sufficient positively influenced the degree of strength gained
by participants in the SUPP group. Given that vitamin D status and protein intake increased
significantly with nutritional supplementation over the course of this study, these observations
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are consistent with previous studies that report an association between strength [55] and lean
body mass [56–58] gains. The results of this subgroup analysis therefore reinforce the potential
of multi-ingredient nutritional supplementation to target several nutritional requirements
simultaneously, increasing its applicability to a wider range of older adults.
In conclusion, we have demonstrated that twice daily consumption of a whey protein-based
supplement containing creatine, vitamin D, calcium, and n-3 PUFA was effective in stimulat-
ing strength and lean body mass gains in the absence of exercise in a group of healthy older
men. Future trials with a larger sample size, and including older women, for a greater duration
would confirm if this supplement represents a viable anti-sarcopenic strategy with the poten-
tial for broader use.
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